ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166199 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166199; 2) Community: the network communities that were significantly associated with the response to NSC 166199; 3) Molecule: the relationships between components within communities and NSC 166199; 4) MDR: the compounds that were significantly associated with the NSC 166199.

NSC Compound Enrichment Correlation
NSC 642324 Null 0.00018474829680001 0.70366609
NSC 3088 Chlorambucil 0.000209886950886021 0.8734943
NSC 606498 Camptothecin Derivative 0.000209886950886021 0.70275239
NSC 610458 Camptothecin Derivative 0.000209886950886021 0.80702401
NSC 639174 Camptothecin Derivative 0.000209886950886021 0.7953481
NSC 671009 2H-Thieno[3',4':4,5]cyclopent[1,2-d]oxazole- 2,7(7aH)-dione,4,6-dibromo-3,3a-dihydro- 0.000209886950886021 0.11331101
NSC 681635 Camptothecin Derivative 0.000209886950886021 0.71661569
NSC 724597 S-(diethylarsino)-3-mercapto-1,2-propanediol 0.000209886950886021 0.097711823
NSC 56410 Porfiromycin 0.000416348839396258 0.79124255
NSC 642328 Benzonitrile, 4-[[1,3,3a,4,9,9a-hexahydro-9-(4-hydroxy- 3,5-dimethoxyphenyl)-6,7-dimethoxy- 1-oxonaphtho[2,3-c]furan-4-yl]amino]-, [3aS-(3a.alpha.,4.beta.,9.alpha.,9a.beta.)]- (9CI) 0.000416348839396258 0.72170101
Total:99  Current:2    [First] [Prev] [Next] [Last]